Cingulate (CINGW) Operating Expenses (2021 - 2026)
Cingulate's (CINGW) quarterly Operating Expenses came in at $5.4 million in Q2 2026, up 16.45% on a YoY basis from $4.6 million in Q2 2025, and down 3.07% quarter-over-quarter from $5.6 million in Q4 2025.
Analysis
Cingulate (CINGW) Operating Expenses (2021 - 2026) Analysis & Trends
Cingulate (CINGW) has reported Operating Expenses for 6 consecutive years, with $5.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Expenses rose 16.45% year-over-year to $5.4 million; the trailing twelve-month figure through Jun 2026 stood at $21.6 million (up 21.3% YoY), and the FY2025 full-year result was $19.9 million, up 27.44% from the prior year.
- Operating Expenses fell to $5.4 million in Q2 2026 per CINGW's latest filing, from $5.6 million in the prior quarter.
- Across five years, Operating Expenses topped out at $6.8 million in Q4 2023 and bottomed at $2.9 million in Q1 2024.
- Historically, Operating Expenses has averaged $4.8 million across 5 years, with a median of $4.6 million in 2025.
- The widest YoY moves for Operating Expenses: up 276.6% in 2022, down 74.03% in 2022.
- Over 5 years, Operating Expenses stood at $4.5 million in 2022, then jumped by 51.89% to $6.8 million in 2023, then dropped by 8.66% to $6.2 million in 2024, then fell by 10.02% to $5.6 million in 2025, then decreased by 3.07% to $5.4 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $5.4 million, $5.6 million, and $6.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.70 Bn | 623.94 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 441.16 Bn | 434.59 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 364.92 Bn | 357.78 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 266.48 Bn | 258.79 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 6.68 Bn |
| 6 | Sanofi | 52.53 Bn | 45.15 Bn | 10.79 Bn | -5.98 Bn |
| 7 | Revolution Medicines | 44.20 Bn | 44.20 Bn | - | 505.13 Mn |
| 8 | Incyte | 25.27 Bn | 20.74 Bn | 1.57 Bn | 976.14 Mn |
| 9 | United Therapeutics | 21.44 Bn | 18.78 Bn | 683.80 Mn | 452.50 Mn |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | 5.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.41 Mn |
| Dec 31, 2025 | 5.59 Mn |
| Sep 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | 4.65 Mn |
| Mar 31, 2025 | 3.71 Mn |
| Dec 31, 2024 | 6.21 Mn |
| Sep 30, 2024 | 3.28 Mn |
| Jun 30, 2024 | 3.21 Mn |
| Mar 31, 2024 | 2.95 Mn |
| Dec 31, 2023 | 6.80 Mn |
| Sep 30, 2023 | 5.75 Mn |
| Jun 30, 2023 | 6.36 Mn |
| Mar 31, 2023 | 3.85 Mn |
| Dec 31, 2022 | 4.48 Mn |
| Sep 30, 2022 | 3.97 Mn |
| Jun 30, 2022 | 4.05 Mn |
| Mar 31, 2022 | 5.01 Mn |
| Dec 31, 2021 | 2.65 Mn |
| Sep 30, 2021 | 15.28 Mn |
| Jun 30, 2021 | 1.42 Mn |